This episode focuses on the process of drug development using the example of the Covid 19 vaccine. It will also provide the listeners with a walkthrough of the phase 3 trial of the Pfizer-BioNTech vaccine. The study type of randomised controlled trials will be briefly explored.

The HLA is approved by The Institute of Leadership & Management, is a certified member of Social Enterprises UK, and is commissioned by Health Education England North East and Health Education England South West. The HLA partners with Medics.Academy and through Medics.Academy its programme is accredited by the Medical School at the University of Central Lancashire. The HLA is also supported by University College London’s Academic Careers Office.